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CHAPTER I
INTRODUCTION
SOME GENERAL AND BIOLOGICAL AND PHYSICAL
CHARACTERISTICS OF HERPESVIRUSES
Every species of animal is suspected of harboring at least one
herpesvirus.

However, since herpesviruses are often difficult to cul

ture , only about twenty viruses have been reported to be in the herpes
virus group, which includes animal and human viruses (16, 25, 34).
Melnick, et _al. (1964) subdivided the herpesviruses into subgroups A
and B.

Group A viruses are released readily from infected cells,

whereas Group B viruses tend to remain cell-associated (17, 34).
Group A viruses include Herpesvirus hominls (formerly herpes
simplex virus) and several similar animal viruses. Group B viruses
include the varicella-zoster virus (chicken pox in children; shingles
in adults), cytomegalovirus, which causes a fatal pneumonia of infants,
and several other human and animal viruses (34).
Herpesviruses are relatively large viruses with an overall
size estimated between 140 and 250 nm (6, 8, 34), with an average size
of 180 to 200 nm (8). The virus is enclosed by a lipid-rich membrane
or envelope which is apparently of host cell origin (6, 8) and which
accounts for the overall particle size.

Because of essential lipids

in the envelope, herpesviruses are inactivated by ether or chloroform
(8, 12, 34).

Group A viruses can obtain their envelopes at the nuclear

membrane but may add additional membranes at the cell surface (6).
Serological studies show that anti-host cell antibodies (e.g., rabbit
anti-HeLa) will agglutinate only enveloped viruses grown in that parti
cular cell line (HeLa).

Anti-herpesvirus antibodies agglutinate mostly

unenveloped viruses (8, 33).

Therefore, the envelope may serve to
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mask the antigenic determinants.

Both enveloped and non-enveloped

viruses are released during Infection, but enveloped particles attach
to host cells more readily and, once attached, have a much higher via
bility or infectlvlty than do non-enveloped viruses. It is possible
that non-enveloped viruses are sensitive to enzymes which may enter
through holes that appear to be in the capsomeres (structural subunits)
(7).
Herpesvirus deoxyribonucleic acid (DNA) is double stranded
with a molecular weight ranging from 54 to 92 x 10^ daltons (6),
According to current quantitative methods, herpesvirus DNA is estimated
to contain enough Information to specify the sequence of up to 140,000
amino acids.

Assuming that genes are not duplicated, only 10 to 20%

of the total genetic information is expressed in tissue culture.

Com

pared to other viruses, herpesviruses contain large amounts of genetic
information for viruses of their size and complexity. Since herpes
viruses tend to establish lifelong infections in their natural hosts,
it is thought that the extra genetic information contributes to the
total infective process in the natural host (16).
SOm CLINICAL ASPECTS Of GROUP
A HERPESVIRTTSES
Clinically, among Group A herpesviruses, it is important to
note that there is a marked change in virulence when a virus is intro
duced into an immature or unnatural host.

Cytomegalovirus generally

causes a subclinical Infection in adults, but it is generally fatal for
infants.

Herpesvirus homlnis (HVH) usually causes a mild infection

in adult humans but causes severe central nervous system damage in
rabbits and mice (8).
In man, HVH infections may take several forms and are often
subclinical.

The clinical response is usually a mild vesicular eruption

of the skin or mucous membranes.

The virus may also cause severe ill

nesses such as stomatitis, Kopsls' varicelliform eruption, meningoence
phalitis, and a generalized, usually fatal, neonatal disease (12).
Herpesvirus homlnis has been categorized into two subtypes:
1 and 2.

The type 1 virus strain causes localized recurrent lesions
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about the lips and mouth.

It can also be involved over wider areas of

skin and cause meningoencephalitis or keratoconjunctivitis (12).

The

type 2 virus strain causes recurrent genital lesions in both men and
women (21), and frequently causes a systemic infection of infants
exposed congenitally (transplacentally) or neonatally via herpetic
lesions in the birth canal.

It can also be involved in keratoconjunc

tivitis or meningoencephalitis (13).

Ui VITRO STUDIES OF HERPETIC INFECTIONS
Biological Aspects of In Vitro Herpetic
Infections
In vitro studies (i.e., in tissue culture) have yielded much
information about the infectious process of herpesviruses. In tissue
culture, HVH has a wide host range, but not all cell lines are equally
susceptible.

Human, simian, rabbit, hamster, mouse, chicken embryo,

and other cell lines are infected with varying virulence (34). Expo
sure to HVH induces an abortive infection in dog kidney cells and inhi
bits the infective process of pseudorabies virus (PRV) in dog kidney
cells (2).
The reproductive cycle can be best described in terms of fac
tors affecting four aspects of the replicative cycle, (i) the duration
of the eclipse or latent period, (ii) the duration of the replicative
cycle, (iii) the yield of virus per cell, (iv) the release of virus
from the infected cells.
(i) The duration of the latent period varies from 3 to 8
hours for most herpesviruses.

It is affected by the temperature of

incubation, by the multiplicity of infection, and by prior infection
of the cells by another mutant strain of virus.

Each cell has a mini

mum latent period when infected with a given virus (e.g., 3 hours for
PRV in rabbit kidney cells, or 5 hours for HVH in HEp-2 cells).

The

period cannot be shortened by increasing the multiplicity of infection.
(ii) The duration of the replicative period of herpesviruses
varies with the virus and the infected cell. It is also affected by
the multiplicity of infection and the temperature of incubation.

The
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reproductive cycle of HVH in HEp-2 cells varies from 13 to 19 hours;
at 37°C with an infective dose of 50 plaque-forming units per cell,
the cycle lasts 17 hours (28). In HeLa at 37°C with an infective dose
of 5 plaque-forming units per cell, the replicative cycle of HVH lasts
12 hours (30).
(iii) The virus yield from infected cells increases exponen
tially from the end of the latent period until almost the end of
the replicative cycle.

Under optimal conditions the yield of HVH from

HEp-2 is 10,000 to 100,000 virons per cell, but only about 0.1 to 10%
of these virons are viable as indicated by their plaque-forming ability
(28). In HeLa about 40,000 virons per cell are produced, of which
0.025% are infective as indicated by their plaque-forming ability (31).
Cells in monolayer usually yield more virus than cells in suspension.
High virus titers are more readily obtained in rapidly growing cells
maintained after infection in enriched medium at pH and temperature
optimal for the particular strain of virus.
(iv) After infectious herpesvirons appear inside infected
cells, release is generally slow and temperature-dependent. Herpes
virus hominis is released more readily from suspended cells at 37°C
than from cells adhering to glass surfaces or cells incubated at
34°C.

Freezing and thawing or sonication release aggregates of virus

from infected cells (28).
Cytopathic effect (CPE), as observed in the light microscope,
for HVH type 2 (strain 196) is generally "ballooning" and detachment
of infected cells, with occasional formation of small syncitia
(giant cells formed by the fusion of several cells).

Certain strains

of PRV normally cause extensive syncitia in infected monolayers of
cells (25). Many authors have generalized the PRV infective pattern
to apply to all herpesviruses. Some strains of HVH in the presence of
specific antibody do form extensive syncitia (11, 25), but strain 196
(used in this study) forms syncitia only occasionally.
Observations made with the electron microscope have shown that
after attachment the viruses are phagocytized into vaculoles in the
peripheral cytoplasm.

The envelope is removed and the naked capsid

passes into the cytoplasm (6). It is likely that two particle types
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are necessary to initiate infection.

Miyamoto and Morgan (1971) report

two types of capsids, designated light and dense, based on electron
density.

Light capsids constitute 53%, and dense capsids constitute

47% of the total number of capsids observed.

Shortly after penetra

tion, dense capsids were observed to be in various stages of disrup
tion; light capsids remained stable for at least one hour after
infection. However, after 20 to 30 minutes most of the light capsids
were devoid of cores.
It was suggested that the DNA released from the dense capsids
near the cell surface transcribes a virus-specific messenger ribonu
cleic acid (mRNA) which codes for an enzyme which renders light cap
sids permeable to their core contents as they approach the nuclear
membrane (20). Parental capsids have not been observed in the nucleus.
Naked capsids appear in the nucleus within 5 to 6 hours after infection
(18, 23), and enveloped virons appear in the cytoplasm about an hour
later. Envelopment of the capsid occurs as the virus buds through the
nuclear membrane or into cytoplasmic vacuoles (6, 23). Late in the
infection, crystal arrays of capsids appear in the nucleus just prior
to cell death (6).
Molecular Aspects of In Vitro
Herpetic Infection
During the course of infection, viral mRNA, which is more
stable than cellular mRNA, is synthesized; this new mRNA is comple
mentary to viral DNA (7).

The activity of DNA metabolism within the

cell is increased. During the period 2 to 8 hours after infection
the activity of thymine kinase, thymidylate kinase, DNA polymerase,
and DNAase Increase; afterward their activities decrease (28). The
increased activity is due in part to the stabilization of host cell
enzymes.

The HVH-coded enzymes differ from host cell enzymeA and

poxvirus-coded enzymes in heat stability^ response to excess substrate,
response to allosteric reactants, and in Michaelis constant (8, 14).
Viral protein synthesis increases during the period 3 to 8 hours
after Infection, after which it declines (28). Host cell protein
synthesis decreases by one-half within 4 hours.

The enzymes which
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appear early in the infection decrease in activity as the rate of
assembly of virus particles from accumulated subunits increases.

Assem

bly and active release continue until the cell dies, usually within
24 hours (8).

CROWTH CURVE STUDIES WITH

Purpose
It was noted by Dr. R. N. Ushijima that when stock pools of
HVH were prepared in different cell lines there were differences in
the rates of appearance of CPE and in the peak yields of virus.

Pri

mary rabbit kidney cells showed rapid CPE but yielded low titers of
virus.

HeLa showed delayed CPE but produced higher titers of virus.

Vero showed rapids CPE and produced the highest virus yield.

Since

these cell lines are used routinely in this laboratory, it was
decided that growth curve information on HVH in these cell lines
would be valuable.
Statement of the Problem
Experiments were designed to determine the time and rate of
synthesis of HVH type 2 (strain 196) in the stable cell lines, Vero,
HeLa, and MAlll (a stable rabbit kidney line) and to determine the
correlation, if any, between the appearance of CPE and virus production
by the respective cell lines.
Experiments were designed to determine the stability of HVH
type 2 (strain 196) at 37°C and to repeated freeze-thaw cycles, since
the virus was exposed to both temperature and freeze-thaw degradation
during preparation.

.

Early trials showed that the titer of the released virus
remained constant for up to 24 hours after the cells detached from
the glass culture surface.

An experiment was designed to determine

whether this release of virus by detached cells was active or passive,
i.e., whether the detached cells were alive or dead.
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Literature Review
There appear

to be no previous studies reported in the liter

ature using either Vero or MA.111 with HVH. Both cell lines have been
used extensively to study RNA viruses (26, 27) and, to some extent,
SV-40 and adenoviruses (29). HeLa cells have been used extensively
in studies of HVH.

Most studies were either electron microscope

examinations of the infectious process or biochemical studies of
Infected cells, but some growth curve information in HeLa cells has
been reported.

Waterson (1968), summarizing Newton and Stoker (1958)

and Siminoff (1964), reports yields ranging from 10 to 20 plaqueforming units per cell—the in vitro plaque method of virus assay in
tissue culture is analogous to the plaquing of bacteriophage on sus
ceptible bacteria (4, 5). Peak yields were obtained 16 hours later
using an Inoculum of 5 plaque-forming units per cell and incubating
at 37°C.
The above studies were of interest but were not directly appli
cable to this study.

Three different strains of HVH were used in

the above studies, none of which were strain 196. The plaque assay
method was not used in this study and lower multiplicity inocula were
used.

However, similar medium, incubation temperatures, infecting

methods, and sampling methods were employed.
Kaplan (1957) conducted stability tests similar to the ones
done in this study.

He conducted both temperature (37°C) and freeze-

thaw stability tests.

Although he used the plaque assay method, his

results were reported in survival percentages and could, therefore,
be directly compared to the results in this study.
virus strain differences to be considered.

Again, there were

From Kaplan's results,

up to 99% loss of virus was expected after exposure to 37°C for
24 hours; little loss of virus was expected after up to five freezethaw cycles.

CHAPTER II
MATERIALS AND METHODS
ROUTINE MATERIALS AND METHODS
General Comments
Work with tissue culture of animal cells requires more rigor
ously sterile conditions and quantitatively cleaner glassware than
does routine bacteriological work. Tissue culture medium Is an Ideal
medium capable of supporting the growth of many contaminant organisms:
bacteria, fungi, and mycoplasma.

Antibiotics can control contaminating

organisms of they are few In number and sensitive to the antibiotics
used.

In nearly all laboratories there Is some degree of airborne

microbial contamination, but If certain precautions are taken, air
borne contamination can be minimized and controlled by the penicillin
and streptomycin

routinely present In tissue culture medium.

An Isolation or "sterile" room Is of prime importance.

The

Isolation room should have minimal in-and-out traffic and should be
equipped with high intensity ultraviolet (U.V.) tubes which are acti
vated when the room is not in use.

A hood with its own U.V. source

should be in the isolation room to provide additional protection to
the main work area.

Minimal in-and-out traffic allows dust to settle

in the room and minimizes entry of outside contamination.

Therefore,

all glassware and equipment routinely used for handling cells should
be stored in the Isolation room.

The U.V. serves to inactivate both

contaminant airborne microbes and any virus that invariably escapes
when Infected culture containers are opened.
Sterilization and Decontamination
Methods
In addition to maintaining a semi-sterile environment, any
8
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equipment which comes Into contact with the cells or cell medium must
also be sterile.

Heat Is the most common means of sterilization.

The hot air oven, employing a temperature of 180°C, Is useful for
certain glassware and other materials which can tolerate the heat.
Since dry heat depends upon desiccation to kill microbes, the time
needed for sterilization depends upon the object to be sterillzied.
The autoclave, employing pressurized steam at 121°C, is the choice for
materials which will tolerate that temperature.

A serious disadvantage

of an autoclave operated by centrally supplied stram (the type at
the University of Montana) is that the additives in the steam to pre
vent rust and mineral deposits in the steam lines are toxic to mamma
lian cells.

However, microbial contamination is generally more of a

problem than toxicity, and methods to minimize autoclave toxicity will
be discussed as they apply.

Filtration is used to sterilize liquids

which will not tolerate autoclave temperatures.
will be discussed below.

Treatment of filters

Ethylene oxide gas is used to sterilize

plastic objects which cannot be autoclaved.

Ultraviolet irradiation

is used to sterilize certain plastic objects and powdered insoluble
antibiotics.
Two filtering systems were available;
Millipore.

the Seitz and the

Both employ air pressure or vacuum to force filtrate through

the filter pad.

The major advantage of the Seitz system is its rela

tively low cost.

The Seitz system employs asbestos pads of low poro

sity, resulting in low flow rates of filtrate. The Seitz filter is
cleaned after use and rinsed well in distilled water.

It is sterilized

in the hot air oven for 40 minutes (any longer chars the pad) to
avoid autoclave toxicity.
The Millipore system, which is more expensive, employs syn
thetic pads of high porosity and more uniform size, resulting in
high flow rate of filtrate at low pressure.

Millipore pads cannot

tolerate dry heat and must be autoclaved.
Both filter systems must be pre-treated with glass-distilled
water prior to use.

The pre-treatment in the Seitz filter helps to

seal the pad and flushes away any debris from the pad. The Millipore
pads have a wetting agent which is toxic and must be removed.

To

10

remove wetting agent from a 293 mm pad, pass four liters of hot glassdistilled water (95 to 100°C) through the pad followed by two liters
of cold (25°C) water.

This treatment also seems to remove any auto

clave toxicity factors.

Specific uses of filters will be discussed

as they apply.
In addition to routine sterilization of equipment, there is
the problem of disposal of contaminated (intentional and unintentional)
materials.

Disposable plastic materials can be merely autoclaved.

Metal containers should be available for storing contaminated materials
prior to autoclaving.

Glassware can be soaked in a dilute bleach

(Chlorox or Purex) solution for about 10 minutes. In culture bottles,
this treatment also detaches any cells from the glass, making cleaning
easier.

The pipette disposal jars should also contain a dilute bleach

solution. Metal caps, plastic caps, and rubber stoppers, which will
not tolerate bleach or which tend to absorb bleach, can be soaked in
70% ethanol.
Cleaning of Glassware
Glassware must be quantitatively clean to support the life
of animal cells.

Animal cells will not tolerate even the small

amounts of metal ions normally found in distilled water. Glassdistilled water must be used in the final rinse of any glassware used
to grow cells.

Â satisfactory supply of glass-distilled water is

prepared by redistilling tap-distilled water in a Bellco single stage
distilling unit with a long column.
The general procedure for washing glassware is as follows:
1.

Rinse in tap water (if it has been soaked in
bleach.

2.

Wash well in tap water and Detergex brand pow
dered cleanser (available from Pharmaseal Labo
ratories, Glendale, California).

3.

Rinse well in tap water.

4.

Soak for about twenty minutes in dilute hydro
chloric acid in distilled water to remove any
residual detergent.

5.

Rinse well in distilled water.
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6.

Rinse In glass-dlstllled water If container
will be used to grow cells or to store medium.

The general procedure Is modified somewhat to fit the glassware
being cleaned, but the basic steps are the same.
Pipettes are drained, the cotton plugs removed, the pipettes
placed In a Detergex solution and autoclaved for 10 minutes.

The

pipettes are rinsed In a commercial rlnser with tap water for 30
minutes, placed in an acid rinse for 5 minutes and finally rinsed three
times in tap-distilled water.

After drying, the pipettes are plugged

with cotton, placed in metal cans and sterilized in the hot air oven
for 60 minutes.
Prescription and media bottles are washed according to the
general procedure and given a final rinse in glass-dlstllled water
and dried.

To minimize autoclave toxicity, a square of Reynolan plas

tic, cut from Brown-ln-Bag cooking wrap, is used as a gasket under the
screw cap to minimize the amount of steam which enters the bottle.
They are autoclaved 10 minutes and put on the drying cycle.
The Cornwall automatic pipette—an adjustable syringe with
a one-way siphon—is disassembled and cleaned. The entire components
receive a final rinse in glass-distilled water, then are wrapped in
foil and autoclaved 10 minutes on fast exhaust to protect the surgical
tubing siphon.
Caps and rubber stoppers are boiled in distilled water.

Caps

are sterilized with the bottle or tube. Rubber stoppers are wrapped
in foil "candlesticks" and autoclaved 10 minutes on fast exhaust.
Culture Media and Solutions
This section describes and discusses media, buffers, and
other solutions needed to handle cells In tissue culture.

To prepare

versene-trypsin (Table 1), mix part A for 30 to 45 minutes on a mag
netic stirrer with about half the NaHCO^ and most of the water; add
B, then mix for 10 to 15 minutes.
when clear.

The solution is ready to filter

Filter through a pad with 0.22 or 0.25 um pores.

in 8-ml amounts in screw-capped tubes and store at -70°C.

Dispense

Versene-

trypsin is used to remove monolayered cells from the glass or plastic
culture surface.
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Table 1.

Chemical Composition of Versene-Trypsln Solution

Solution

Material

gm/1. glass-distilled H^O

A.

NaCl
KCl
Glucose
Trypsin

8.0
0.4
1.0
1.5

B.

NaHCO]
Versene

0.58
0.2

Phosphate buffered saline (PBS) (Table 2) without
Ca

ions is designated Pd.

and

Since these cations inhibit the action of

trypsin, Pd is used Instead of PBS as a wash for monolayered cells
prior to trypsinizatlon for further passage.

The cation-deficient

buffer is prepared as a lOx stock which is diluted prior to use.

The

resultant Isotonic solution is decanted into 100 ml milk dilution
bottles and autoclaved 15 minutes with the caps snug to minimize
mixing with steam.

The autoclave is set on slow exhaust cycle.

Table 2. Chemical Composition of Phosphate Buffered Saline (Dulbecco
and Vogt, 1954, a fie b)

Solution

Material

gm/1. glass-distilled HgO

A.

NaCl
KCl
Na2HP04 ° THLO
KHgPO^

8.0
0.2
2.15
0.2

B.

MgCl2 * 6H2O
CaCl2

0.1
0.1

Minimal Essential Medium (MEM) is prepared from the materials
listed in Table 3, then filtered through a 0.22 or 0.25 um filter pad.
Powdered MEM is available through Grand Island Biological Company.
Potassium penicillin C and streptomycin sulfate are available through
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Calblochem.

Other antibiotics used were Chlorotetracycllne, Kanamycin,

and Neomycin (antl-mycoplasma agent) and Mycostatln or Nystatin (anti
fungal agent).

These are available from Grand Island Biological

Company, DIFCO, and others. Product information is provided by the
suppliers.
Calf serum can be collected at a local slaughter house.

Fetal

calf blood is preferred, but blood from animals under 8 months of age
is acceptable.

These animals have minimal amounts of gammaglobulins

In their serum.
Glass containers are most appropriate for collecting blood
since they minimize hemolysis.

One-gallon mayonnaise jars work well.

The blood is allowed to clot for several hours, then the clot is
cut in quarters and allowed to stand overnight in the cold.

The serum

decanted from the jars is put in 250 ml centrifuge tubes, spun at
2,000 rpm for 15 minutes in an International H9070 size 2 centrifuge
with a swinging bucket head, and allowed to free wheel to a stop. The
serum is carefully pipetted from the tubes by suction apparatus.

It

is then cleared by filtration through a filter pad with 4 um pores.
If filter-sterile serum is desired, it should be reflltered through a
0.22 or 0.25 um pad.

The complement in all sera, sterile or non-

sterile, should be inactivated at 56°C for 30 minutes prior to use.
In this study, MEM with 3 and 5% calf serum was used.

Thirty

milliliters of 50 ml of serum were added to one liter and designated
3 and 5%, respectively.
Serum was stored in 100 and 250 ml amounts in whirl bags if
non-sterile, and in 500 ml amounts in bottles if sterile.

The media

were prepared in large volumes both for this project and other pro
jects in the laboratory.

Stocks of media containing 5 or 10% serum

or no serum were prepared monthly and stored at 4°C.
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Table 3. Composition of the Medium Prepared with Eagle's Minimal
Essential Medium

Material

Glass-distilled H^O
Commercial powder
NaHCOPenicillin
Streptomycin
Serum

Amount of Material Used

1.0 liter
9.9 gm
1,5 gm (varies)
100 units/ml
100 ug/ml
*
20 to 200 ml

Serum may be omitted and sterile serum added as needed.

The bottles used to store the medium or serum were either
500 ml bottles which originally contained commercial fetal calf serum
or 500, 1000, or 1500 ml bottles which originally contained isotonic
saline and were obtained from a local hospital.
For general laboratory equipment, John Paul's Cell and Tissue
Culture (1959) contains basic lists of laboratory apparatus and
materials as well as a partial list of companies which supply research
equipment.

EXPERIMENTAL MATERIALS AND METHODS
The Virus
Herpesvirus hominis type 2 (strain 196) was obtained from
Dr. W. E. Rawls of Baylor University College of Medicine. Stock
pools of virus were prepared in Vero (stable Green monkey kidney)
cells.

After the culture medium was removed from monolayers of Vero
7
cells in 8 oz. prescription bottles containing about 1 x 10 cells,
1.6 to 4.0 X 10^ TCID units of virus in 1 ml culture fluid were
allowed to adsorb to the cells for one hour at 37°C.

At the end of

one hour, 15 to 20 ml of MEM with 3% calf serum were added to the
bottle.

After 30 to 36 hours, or when most of the cells had detached

from the glass, the cultures were frozen and thawed twice to disrupt
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the cells and to release cell-associated virus. The cellular debris
was pelletted In an international H9070 size 2 centrifuge at 1,000 rpm
for 10 minuteso

The supernatant culture fluid was collected and stored

In flame-sealed glass ampules In 1-ml amounts at -70°C until use.

The

stock pool was tltered by pooling two ampules of virus and titration
by the 50% Tissue Culture Infective Dose (TCID^Q) method.
The TCID^Q by the Mlcrotiter Method^
Special materials used for this method were Falcon 3040 Microtest II tissue culture plates obtained from Falcon Plastics, Oxnard,
California; Mlcrodlluters (0.05 ml volume), available from Cooke
Engineering Company; and Micropipettes (0o05 ml volume), obtained from
Microbiological Associates, Bethesda, Maryland.
The Falcon Microtest II tissue culture plate has 96 wells in
an 8 by 12 arrangement. Using a 0,05 ml micropipette, in which each
drop is calibrated at 0.05 ml, one drop of MEM with 3% calf serum was
added to each well.

Appropriate serial 10-fold dilutions of virus

in quadruplicate were diluted with a 0<,05 ml microdlluter in three
step 2-fold series.

Three dilutions of each sample were plated.

The microdlluter was dipped in 95% ethanol and rotated
between the fingertips.

_3
After flaming, and starting with the 10

dilutiont an entire sanqple was plated before sterilizing the microdl
luter again.

A diagramniatic representation of the tissue culture

plate is shown in Figure 1.
The microdlluter was allowed to cool for about 15 seconds, then
3
dipped into the 10 dilution. The microdlluter was rotated for 10
cycles back and forth with the fingertips, then placed into the 2
well in the extreme right of the 10 ^ series and rotated for 10
cycles.

The microdlluter was removed from the 2 ^ well, placed into

the 2

well, and rotated for 10 cycles. The microdlluter was
-2
-3
removed from the 2
well, placed into the 2
well, and rotated for

10 cycles. Finally, the microdlluter was removed from the last well
and reloaded in the 10

dilution.

The above was repeated until the

Hliçrotiter is a trademark of Cooke Engineering Company of
Alexandria, Virginia.
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three dilutions were plated, the microdlluter was sterilized in alcohol
and flamed, and the next sample was started.

The process was made

faster when two or more mlcrodlluters were used simultaneously.
With dilutions in test tubes, two mlcrodlluters was the practical
limit.

When all samples were plated, 0.05 ml of a suspension of

2 X 10^ Vero cells per ml of MEM plus 3% calf serum was added to each
3
well, or 1 X 10 cells per well. The plates were read at 48 hours by
noting the presence of absence of CPE in the monolayers in the well.

10"^
Sample #1 $ e 4 e
-®- -e- «e- •©•-©• -®-

-®0
0 0 0 0

10~3
0 0 0 0
0 0 0 0
0 0 0 0

Controls

0 0 0 0
0 0 0 0

0 0 0 0
0 0 0 0

0 0 0 0
0 0 0 0

Sample #2

$- -e- # MB-

# 0 0 0
0 0 0 0
0 0 0 0

0 0 0 0
0 0 0 0
0 0 0 0

# $ # 0

10"^

Figure 1. Diagrammatic Representation of a Mlcrotest II Plate
To calculate the TCID^Q, the Reed-Muench formula was modified
from the original described by Lennette and Schmidt (15).

Data was

arranged according to Table 4 (e.g., Sample 1, from Figure 1).
The accumulated values for the number of wells showing CPE
(column e) or not showing CPE (column f) are obtained by adding
columns c and d in the direction indicated by the arrows.

The

accumulated mortality ratio (column g) represents the accumulated num
ber of wells showing CPE (column e) over the total number of wells
2
accumulated (column e + column f). For example. In the 4 x 10 reci
procal of the virus (RV) dilution, there were three wells showing CPE
in a total of four wells.
2
In the example, the percentage CPE in the 4 x 10 RV dilution
2
la higher than 50%; the percent CPE in the next RV dilution, 8 x 10 ,
is lower than 50%.

The 50% endpoint lies between these two RV dilutions.

The proportionate distance of the 50% endpoint from the
dilution next above 50% is obtained as follows:
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Proportionate. '^%r.boL1on
Distance
(Percent CPE at RV dil, _
next above 50%)

(Percent CPE at RV dil,
next below 50%)

75 - 50
75-0
25
75
0.33

Since logarithmically the distance between any two dilutions
is a function of the Incremental steps used in preparing the series,
it is necessary to correct (i.e., multiply) the proportionate distance
by the logarithm of the dilution factor. In a 2-fold dilution series,
the logj^Q(2) • .301 is used as the correction factor. Therefore:

The logarithm of the TCID^Q ^
endpoint titer

(The logarithm of the RV dilution next
above 50% CPE)
+
(The proportionate distance multiplied
by the logarithm of the dilution
series used)
or

[logiQ(4 X 10^)] + [(0.33)(logio(2))]
[(0.33)(.301)]

11
[2,602]

+

[0.100]

-

2.702

Since the volume of the culture fluid sample is 0.05 ml, the

[iGg^Q(TCID^g)] = [2.702/0.05 ml]
[TCID^Q] = [5.4 X 10^ units/0.05 ml]
= [1.08 X 10^ units/ml]
= [1.1 X 10^ units/ml]

In cases such as Sample #2 in Figure 1, where the RV dilution
1
2
next above 50% is 8 x 10 , and the next below 50% is 2 x 10 , which is
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1
not a 2-fold increment, the average of 8 x 10 and 1 x 10 , or 9 x 10 ,

was used to minimize error.

Table 4. Data Arrangement for Reed-Muench Formula

Reciprocal
of Virus
Dilution
a

Accumulated Values
Mortality
No CPE
Ratio
Percent
f
h
8

CPE
Ratio

CPE

b

c

d

e

2 X 10^

4/4

4

0

19

0

19/19

100

4 X 10^

4/4

4

0

15

0

15/15

100

8 X 10^

4/4

4

0

11

0

11/11

100

2 X 10^

4/4

4

0

7

0

7/7

100

4 X 10^

3/4

3

1 'i

3

1

3/4

75

8 X 10^

0/4

0

4

0

5

0/5

0

2 X 10^

0/4

0

4

0

9

0/9

0

4 X 10^

0/4

0

4

0

13

0/13

0

No CPE

CPE

*The reciprocal of the virus dilution is abbreviated as the RV
dilution in this procedure.

Cells
The cells used for this experimental series were Vero, HeLa, and
MAlll.

The few laboratory rabbits available for this study carried a

vacuolating virus which appeared about 72 hours or more after their
kidney cells were cultured. Because of this and other difficulties,
primary rabbit kidney cultures were not included in the study.
The Vero cell line was derived from a culture from an African
Green monkey kidney line by Yasumura and Kawakita (1). The HeLa line
originated from a human carcinoma of the cervix and was established
by Gey, et al. (9).

The MAlll line is a stable rabbit kidney line

stabilized after numerous passages by Vincent (29).
The MAlll line was received from Microbiological Associates
in Medium 199 and 10% fetal calf serum.

It was transferred to MEM

with 10% calf serum and adapted to MEM with 5% calf serum which was
the standard medium used to grow stock cultures of stable cell lines.

On Initial passages, MAlll was split 1:2 as recommended by Microbiolo
gical Associates.

It was found that cells could be split 1:5 on clean

glass and 1:10 on "used" glass, as was standard procedure for Vero
and HeLa cells.

Used glass is glassware that was used for growing

cells and which has not been reprocessed.

Glassware was used until

the cells began sticking to the glass during passage.
The cells lines, which were grown in 8 oz. prescription bottles,
were passed by trypsinization of monolayers and reseeding part of the
cells.

Prior to the addition of 1 ml of versene-trypsin solution to

each bottle, the monolayer was washed twice with about 5 ml of Pd,
incubated in 10 to 15 ml of Pd for 5 minutes, and washed once more
with 5 ml Pd.

The Pd wash served to remove Mg

and Ca

any other serum factors which inactivate trypsin.

ions and

When the cells

detached from the glass (5 to 10 minutes), the suspension was mixed
with 10 ml of growth medium. For maintaining stock cultures, 1 to
2 ml of this cell suspension was left in each bottle and 20 ml of
fresh MEM with 5% calf serum was added to each bottle.
Cells seeded on clean glass were gassed with air containing 5%
COg to complete the Earle's HCO^ /COg buffer used in MEM.

Cells seeded

on used glassware generate sufficient CO^ to complete this buffer.
Microtest plates were placed in a gas-tight box which was gassed with
air with 5% COg. The temperature of incubation for growing cells and
for conducting the growth curve studies was 37°C.
When known numbers of cells were desired, the cells were
counted by using a hemocytometer. A hemocytometer has a grid of 16
2
large squares measuring 1 mm . A glass coverslip restricts the chamber
3
depth to 0.1 mm. Therefore, each square represents 0.1 mm of cell
suspension.

The cells are counted in the 4 comer squares which are

in turn subdivided into 16 smaller squares for ease of counting.

The

total number of cells in the 4 sqaures is divided by 4 to get the
3
3
3
average cell count per 0.1 mm . There are 1000 mm per 1.0 cm , and
3
1.0 cm is approximately 1.0 ml. Therefore, the average cell count
3
4
per 0.1 mm multiplied by 10 is a good estimate of the number of
cells per ml.

Needless to say, if any other dilutions are made before

the cell count is taken, they must be considered in the calculations.

CHAPTER III
RESULTS
For the growth curve studies, 3 oz. prescription bottles were
seeded with 5 x 10^ cells on 10 to 12 ml of MEM with 5% calf serum.
The cells were allowed to grow monolayers of 4 x 10^ cells as
determined by trypsinizing random cultures and counting the cells in
a hemocytometer.

The monolayers were infected with 1.6 to 2.0 x 10^

TCID^Q units of HVH type 2 (strain 196) in 1.0 ml medium.

was adsorbed for 60 minutes at 37°C.

The virus

After the adsorption period the

cultures were washed three times with 10 ml Fd to remove unadsorbed
virus.

Finally, 8 ml of MEM with 3% calf serum was added to the

cultures.

The saiiq>les taken at this time were plotted at Time = 0.

Released virus was sampled by adding 0.5 ml of MEM with 3%
calf serum to the culture, mixing, then removing 0.5 ml of culture
fluid.

Total virus was sampled by freezing and thawing the culture

three times to disrupt the cells and to release cell-associated
virus.

If released and total virus were sampled simultaneously from

the same culture, the released virus sample was taken as above prior
to freezing the culture.

All samples were assayed for virus by the

TCIDgg method described in the Materials and Methods section.
The growth curves of HVH type 2 in all three cell lines were
superficially similar to each other although different in detail.
showed latent periods where the residual virus titer fell.

All

After

sufficient time to initiate assembly of virus, the titers rose, passing
quickly into log growth phase. Foci of CPE appeared toward the end
of the latent period.

Finally, there were decelerated growth and

terminal growth phases.

All cells had detached from the glass sur

face by the end of the decelerated growth phase.

During the terminal

phase the virus was not being replicated, but cell-associated virus
20
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was released slowly as the cells broke up due to autolysis.
For Vero cells (Table 5, Figure 2), the latent period for
total virus was about three hours. After four hours the titer had
risen and replication was In log phase.

Between twelve and fourteen

hours replication had slowed, and by sixteen hours terminal phase
was reached.

The latent period for virus release was about four hours.

Release reached log phase by six hours, slowed by twenty hours and was
terminal by twenty-four hours.

The peak total virus titer was about

1.6 X 10^ TCID^Q units per ml of culture fluid.

The peak titer of

virus released was about 5.2 x 10^ TCID^Q units per ml of culture fluid.
Peak titer was determined by taking the mean of the titer of all
samples taken after terminal phase was reached.
For HeLa cells (Table 6, Figure 3), the latent period to
total virus replication was about four hours.

After six hours the

titer had risen and replication was in log phase. By twenty hours
replication had slowed, and by twenty-four hours replication was in
terminal phase.

The latent period for virus release was about four

hours.

After six hours the titer had risen and release was in log

phase.

The release slowed between eighteen and twenty hours and was

terminal by twenty-four hours.

Peak total virus titer was about

7 X 10^ TCID^Q units per ml of culture fluid. Peak released virus titer
was about 3.0 x 10^ TCID^Q units per ml of culture fluid.
For MAlll cells (Table 7, Figure 4), the latent period for
total virus replication was about six hours. Log phase was reached
shortly after eight hours.

Replication slowed by eighteen hours and

was terminal by twenty hours.
was about nine hours.

The latent period for virus release

Log phase was reached by twelve hours.

Release

slowed by eighteen hours and was terminal by twenty hours. Peak total
5
virus titer was about 8.1 x 10 TCIDrn units per ml of culture fluid.
50
Peak released virus titer was about 1.1 x 10 TCID^Q units per cell.
Herpesvirus hominls type 2 (strain 196) tended to remain
cell-associated in all three cell lines, as Indicated by the differences
between total and released virus titers.

In Vero cells 67.5% of the

virus remained cell-associated; in MAlll cells 87.3% of the virus
remained cell-associated. In HeLa cells 57% of the virus remained
cell-associated.
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A thermal stability test at 37°C was conducted by suspending
an ampule of stock virus in a total of 10 ml of MEM with 3% calf serum
in a screw capped test tube.

At desired times, 0.5 ml of virus sus

pension was removed and assayed by the TCID^Q method.

The tube was

gassed with air plus 5% CO^ each time it was opened to maintain pH 7.
It was found (Figure 5) that after a relatively stable period
of about five hours the virus became unstable.

About 70% of the virus

was lost in ten to twelve hours and about 95% of the virus was lost
in twenty-four hours. By extrapolation, the half-life of HVH type 2
was about eight hours.
Freeze-thaw stability was determined by suspending stock virus
in 10 ml of MEM with 3% calf serum.

A dry ice-alcohol bath was used

to freeze the sample, and warm water was used to thaw it.

The screw

capped test tube was gassed with air each time it was opened to
flush the COg which entered the tube from the dry ice bath.

After

each freeze-thaw cycle 0.5 ml of the virus suspension was removed and
assayed by the TCID^Q method.
The freeze-thaw stability test (Figure 6) showed a slight rise
in titer after the first cycle, then a stable period of two cycles,
followed by loss of virus on subsequent cycles. Half the peak titer
of virus was lost by the seventh cycle.
A trial was conducted to verify that release of virus by
cells after they detach from the culture surface were passive (i.e.,
that the cells were dead and virus was released when the cells dis
rupted due to autolysis).

A 3 oz, prescription bottle containing

4 X 10^ cells was infected with 2 x 10^ TCID^Q units of virus by the
same methods used in the growth curve studies. After twenty-two hours
the detached cells were pelletted at low speed (1,000 rpm in an
International H9070 centrifuge).

The cells were washed twice by

resuspending them in 10 ml MEM with 3% calf serum and 1.0 ml samples
were removed, after gently rocking the tube to resuspend the cells
at two-hour intervals for six hours.

Of the sample, 0.5 ml was

used to assay for released virus by the TCID^Q method, and the balance
was used to make cell counts in a hemocytometer.
The trial (Table 8) shows a slight increase in released virus
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titer accompanied by a slight loss in cell count, suggesting that virus
was released from the detached cells as the cells were disrupted by
autolysis.
Table 9 shows the peak total and released virus titers
expressed as yield per cell In the infected monolayer.

This comparison

makes it possible to relate this study with those in the literature.
These data were calculated by taking the average yields per ml of cul
ture fluid, and dividing by 4 x 10^ cells.

Vero cells released 1.1

TCID^Q units per cell and produced 3.2 TCID^^ units per cell. HeLa
cells released 0.6 TCID^Q units per cell and produced 1.4 TCID^Q units
per cell.

MAlll cells released 0.22 TCID^q units per cell and pro

duced 1.6 TCID^Q units per cell.
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Table 5. Herpesvirus hoïïilnls type 2 (strain 196) Replication in a
Monolayer of 4 x 10^ Vero Cells in 8 ml Minimal Essential Medium with
3% Calf Serum: Infective Dose 1.6 to 2.0 x 10 TCID ^ Units; Incubation
Temperature 37 C.
*

Time

Released
Trial 1
Trial 2

Trial 1

0

1.6 X 10^

3

8.0 X 10^

4

—— —

1.1 X 10^

6

1.1 X 10^

———

4.0 X 10^

8

———

2.0 X 10^

2.0 X 10^

9

5.7 X 10^

———

12

1.6 X 10^

6.4 X 10^

15

1.0 X 10^

———

16

2.3 X 10^

8.0 X 10^
—— —

6.8 X 10^

Total
Trial 2

5.5 X 10^ 2.3 X 10^
1.4 X 10^
—

2.3 X 10*
—'

1.6 X 10^
2.3 X 10^

—

Trial 3

———

5.6 X 10^
——

1.6 X 10^
———

4.0 X 10^ 1.4 X 10^
8.0 X 10^

——

———

1.3 X 10^

18

1.1 X 10^

———

———

8.0 X 10^

———

20

———

2.0 X 10^

———

——

2.3 X 10^

21

5.7 X 10^

———

6.4 X 10^

5.7 X 10^

———

24

8.0 X lof

3.6 X 10^

6.4 X 10^

2.5 X 10^

28

———

4.5 X lof

———

1.4 X 10^

Time expressed in hours.

—— —

25

i

Ë

i
total virus
released virus
g
w
Tim« in hours

Figure 2. Herpesvirus hominis type 2 (strain 196) Replication in a
Monolayer of 4 x 10 Vero Cells in 8 ml Minimal Essential Medium With
3% Calf Serum; Infective Dose 1.6 to 2.0 x 10^ TCID _ Units; Incubation
Temperature 37 C.

26

Table 6. Herpeavlrua homlnla type 2 (strain 196) Replication in a
Monolayer of 4 x 10^ HeLa Cells in 8 ml Minimal Essential Medium With
3% Calf Serum; Infective Dose 1.6 to 2.0 x 10^ TCID^Q Units; Incubation
Temperature 3/ C
*

Time

Trial 1

0

6.0 X 10^

3

2.0 X 10^

Released
Trial 2

Total
Trial 1

Trial 2

3 . 6 X 10^

4.7 X 10^

1.6 X 10^

—

———

——

5.7 X 10^

2 . 0 X 10^

4
6

3.0 X 10^

—

8.0 X 10^

8

———

5 . 0 X 10^

———

2.5 X 10^

9

1.4 X 10*

———

—— —

12a**

3.6 X 10^

1 . 1 X 10^

1.6 X 10^

5.7 X 10^

12b**

2.0 X 10*

—

9.3 X 10^

———

15

2.5 X 10*

—

———

16

———

1 . 0 X 10^

18

5.6 X 10^

—

2.6 X 10^

———

20

———

5 . 7 X 10^

———

2.2 X 10^

21

1.0 X 10^

—

24

2.1 X 10^

4 . 4 X 10^

28

———

2 . 5 X 10^

2.9 X 10^

—

2.0 X 10^

———

1 . 1 X 10^
8 . 0 X 10^

*Time expressed in hours.
**The growth curve was split at 12 hours. T = 12a was the end
of one half, and T = 12b was the start of the other half.
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Figure 3. Herpesvirus hominls type 2 (strain 196) Replication in a
Monolayer of 4 x 10 HeLa Cells in 8 ml Minimal Essential Medium With
3% Calf Serum; Infective Dose 1.6 to 2.0 x 10° TCID^g Units; Incubation
Temperature 37°C
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Table 7. Herpesvirus hominis type 2 (strain 196) Replication in a
Monolayer of 4 x 10 MAlll Cells in 8 ml Minimal Essential Medium With
3% Calf Serum; Infective Dose 1,6 to 2.0 x 10 TCID^» Units: Incubation
Temperature 37°C
*

Released
Trial 2

Time

Trial 1

0

1.1 X 10^

3

4.0 X 10^

4
6

—

3.0 X 10^

8
9

Trial 2

7.7 X 10^

2.0 X l(f

— ——

3.0 X 10^
——

2.3 X 10^

—

6.8 X 10^
2.0 X 10^
—

4.5 X 10^

2.5 X 10^

12a**

8.0 X 10^

12b**

4.5 X 10^

15

1.6 X 10^

16
18

6.4 X 10^

Total
Trial 1

5.0 X 10^

3 . 0 X lo'^

2.2 X 10^
———

1.6 X 10^
8.0 X 10^

20

6.4 X 10^

—

2.0 X 10^

1.3 X 10^
9.3 X 10^

4.7 X 10^

21

8.0 X 10^

——

—— —

—— —

24

1 . 3 X 105

1 . 6 X 10^

1 . 6 X 10^

5 . 7 X 10^

28

———

1 . 8 X 10^

6 . 4 X 10^

Time expressed in hours.
The growth curve was split at 12 hours. T = 12a was the end
of one half, and T = 12b was the start of the other half.
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Figure 4. Herpesvirus hominis type 2 (strain 196) Replication in a
Monolayer of 4 x 10^ MAlll Cells in 8 ml Minimal Essential Medium With
3% Calf Serum; Infective Dose 1.6 to 2.0 x 10 TCID^Q Units; Incubation
Temperature 37°C
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Table 8. Extended Release of Herpesvirus homlnls type 2 (strain 196)
by Detached Vero Cells in 10 ml Minimal Essential Medium With 3%
Calf Serum; Incubation Temperature 37°C

Time in Hours

TCID^Q of Released Virus

Cell Count

0

6.36 X 10^ units/ml

7 x 10^/ml

2

6.36 X 10^ units/ml

5 x 10^/ml

4

6.00 X 10^ units/ml

6 x 10^/ml

6

8.00 X 10^ units/ml

5 x 10^/ml

Table 9. Peak Herpesvirus hominis type 2 (strain 196) Titers in
Different Stable Cell Lines Expressed in Terms of TCID^Q Units pe
in the Infected Monolayer; Incubation Temperature 37°C

Cell Line

Released Virus Titer

Total Virus Titer

Vero

1.10

3.2

HeLa

0.60

1.4

MAlll

0.22

1.6

CHAPTER IV

DISCUSSION
There appears to be no precedent in the literature for dis
cussing the Vero or MAlll culture and HVH systems.

Both cell lines

have been used extensively for the study of RNA viruses (26, 27) and
to some extent with SV-40 and adenoviruses (29).

This study indicated

that Vero was superior to HeLa cells in its capacity to support the
reproduction of HVH type 2. Vero was also found to be superior to
HeLA as an indicator cell for the assay of HVH type 2 because it
showed CPE sooner than HeLa, espeically under low multiplicity con
ditions,

Furthermore, in pilot studies, it was found that Vero could

be maintained in monolayer for longer periods of time than HeLa.

The

MAlll cell line was at least equal to HeLa in its capacity to support
HVH type 2 reproduction, but it was not equivalent to primary rabbit
kidney cells as it was hoped to be. The initial observations which
prompted this study indicated that primary rabbit kidney did not
support the growth of HVH type 2 as well as HeLa did.
There has been extensive work with the HeLa and HVH system, and
some growth curve data has been published.

Waterson (1968), summa

rizing a paper by Newton and Stoker (1958), reports that HeLa pro
duced 10 plaque-forming units per cell.

Siminoff (1964), working

with two strains of HVH, reports yields of 16 and 50 plaque-forming
units per cell.

In both studies 5 plaque-forming units per cell were

used as initial inocula.

The differences in yield of this study

compared to yields reported in the literature are probably due to a
combination of initial infective dose, strain differences in the virus,
and to the relative sensitivity of the assay methods.
The stability tests (Figures 5 and 6) compared closely with
those done by Kaplan (1957).

He reports less than 1% survival of his
32
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H-4 strain of HVH after 24 hours at 37°C. In this study, HVH type 2
(strain 196) had a survival rate of less than 5% after 24 hours.
Kaplan's freeze-thaw material shows a rise in titer that he attributes
to disruption of virus aggregations, a stable period of two or three
freeze-thaw cycles, and finally, loss of virus on subsequent cycles.
The results of this study (Figure 6) show a similar pattern, with
50% loss by cycle 7 and 70% loss by cycle 9.

After the first three

cycles, roughly 10% loss of virus titer can be expected with each
subsequent freeze-thaw cycle.
This Study showed
cell lines.

different growth patterns in the different

The log growth phase in both Vero and MAlll had a

steeper slope than did the log phase of HeLa.

As mentioned in the

introduction. Group A viruses show changes in virulence when intro
duced into unnatural hosts.

Herpesvirus hnmin1a infection in man is

usually mild, but in the absence of immune mechanisms the virus is
able to infect all the cells in the culture. The steeper slopes
of the log growth phases of Vero and MAlll and their subsequent earlier
death may indicate part of the reason for the severity of HVH infection
in monkeys and rabbits.

The virus had a longer latent period in

MAlll than in either Vero or HeLa.

Since rabbits are not as phylogene-

tically close to humans as monkeys, HVH may not be able to use the
enzyme systems present in rabbit cells as efficiently as it uses the
enzyme systems in human or monkey cells.

After the latent period,

virus-coded enzymes play a more important role in the infection (8, 14).
Once the virus-coded enzyme systems are established, there are no
genetic factors, as found in human cells, to retard the infection in
either Vero or MAlll.
Initial trials showed that the released virus titer remained
stationary for about 48 hours before falling. It was presumed that
cell-associated virus was being released from the detached cells at a
rate to compensate for thermal lability. Detached Vero cells resuspended in fresh MEM plus 3% calf serum showed a slight rise in virus
titer and a slight loss In cell count (Table 6).

The growth curve

studies showed the presence of a viable cell-associated virus which is
released when the cells are disrupted.

This test verified a slight
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rise in virus titer with a slight loss in cell count. This study was
conducted within the time limit of the stable period in the viral
thermal lability curve, and the cells were put under more stress for
this test than in the pilot growth curve studies when they were not
pelletted and resuspended.

All factors considered, it is feasible that

enough virus was cell-associated and could be released by cell
break-up due to autolysis to keep the released virus titer relatively
stable.

Pilot studies with Vero also showed that the total virus titer

fell within 36 hours.

From the above, it can be concluded that

detached cells are dead and are no longer replicating virus.
In all three cell lines, ballooning and detaching of cells
seemed to be directly related to virus production; as more cells
ballooned, more virus was detected. All cells in all three cell
lines detached within 18 to 24 hours, Vero being the first to detach
completely and HeLa and MAlll detaching later.
In the preparation of stock pools, it was noted that most
HeLa cells detach from the glass culture surface after 48 to 60 hours.
Vero cells detach after 26 to 30 hours.

Since virus production seems

to be related to the appearance of CPE, the lower titers observed in
HeLa are probably a result of the slower rate of virus replication in
HeLa, the resultant lower peak titer, and to thermal inactivation of
the virus at 37°C.

CHAPTER V

SUMMARY

It was noted by Dr. R. N. Ushijlma that when Herpesvirus hominis
was prepared in different cell lines, there were differences in peak
titers of virus produced.

It was decided to do growth curve studies to

determine the rate and time of release of HVH type 2 (strain 196) from
the cell lines, HeLa, Vero, and MAlll, and to correlate, if possible,
the appearance of CPE with the production of virus.

Stability tests

were done; a determination of the viability of detached cells was
done.
Monolayers of 4 x 10^ cells in 3 oz. prescription bottles were
infected with 0.5 TCID^Q units of virus.
for total and released virus.

The cultures were sampled

The virus was assayed by the Micro-

titer^ method, and the 50% Tissue Culture Infective Dose (TCID^Q)
was calculated by a modified Reed-Muench method.
Cell-free virus was resuspended in MEM with 3% calf serum, and
the virus was tested for stability at 37°C and for stability when
exposed to repeated freeze-thaw cycles.
Detached infected Vero cells were pelletted and resuspended
in fresh MEM.

Virus assays and cell counts were done at two-hour

intervals for six hours.
The growth pattern of HVH was different in each cell line.
With respect to total virus, the latent period in Vero was about 3
hours, in HeLa about 4 hours, and in MAlll about 7 hours.

Peak titers

were produced in 14 hours by Vero, in 24 hours by HeLa, and in 16
hours by MAlll, The virus tended to stay cell-associated in all cell
lines.

In Vero, 67.5% of the virus remained cell-associated, and in

HeLa 57% of the virus remained cell-associated; 87.3% of MAlll virus
^Trademark of Cooke Engineering Co., Alexandria, Virginia.
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remained cell-associated.

The virus remained cell-associated for a

relatively longer time in MAI11 than in Vero or HeLa.

Cytopathic

effect appeared in foci at the end of the latent period, and all Cells
had detached by the time peak titers were produced.
Peak total virus titers were 3.2 TCID^Q units per cell for
Vero, 1.4 TCIDgg units per cell for HeLa, and 1.6 TCID^Q units per
cell for MA.111. Peak titers for released virus were 1.1 TCID^Q units
per cell for Vero, 0.6 TCID^Q units per cell for HeLa, and 0.22 TCID^Q
units per cell for MAlll.
Both the thermal stability test and the freeze-thaw stability
test showed brief stability followed by lability. The virus was
stable for about five hours at 37°C and over three freeze-thaw cycles.
The half-life of the virus at 37°C was about eight hours, and half
the virus titer was lost after seven freeze-thaw cycles.
It was concluded that detached cells were dead and released
cell-associated virus passively as they broke up due to autolysis.
It was also concluded that the lower peak titers produced
in HeLa

with respect to Vero when stock pools were prepared were a

function of the slower replication rate in HeLa and the lower peak
titer produced by HeLa reduced further by thermal inactivation of the
virus.
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APPENDIX
PARTIAL LIST OF SUPPLY COMPANIES

Bellco Glass Company, Inc.
340 Edrudo Road
Vlneland, New Jersey
08360
Bloquest
P.O. Box 243
Cockeysville, Maryland
Calblochem
P.O. Box 12087
San Diego, California

21030

92112

Cole-Parmer Instrument Company
745 North Oak Park Avenue
Chicago, Illinois
60648
Cooke Engineering Company
Medical Research Division
735 N. St. Asaph Street
Alexandria, Virginia
22314
Coming Glass Works
Laboratory Products Division
Coming, New York
14380
Dlfco Laboratories
P.O. Box 5058A
Detroit, Michigan
48232
Flow Laboratories
1710 Chapman Avenue
Rockville, Maryland

20852

Grand Island Biological Company (GIBCO)
3175 Stanley Road
Grand Island, New York
14072
Kimble Products, Division of Owens-Illinois
Toledo, Ohio
43601
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Miles Laboratories, Inc,
Research Division
P.O. Box 272
Kankakee, Illinois
60901
Microbiological Associates
4733 Bethesda Avenue
Bethesda, Maryland
20014
Sargent-Welch Scientific Company
7300 North Linder Avenue
Skokie, Illinois
60076
Van Waters and Rogers Scientific Company
P.O. Box 320
San Francisco, California
94119
or
P.O. Box 23
High Brdge Station
Bronx, New York
10452

